Hormone levels may predict breast cancer risk
Higher levels of certain sex hormones may lead to a significantly higher risk of developing breast cancer for women, according to a new study out of Harvard Medical School.
Higher levels of certain sex hormones may lead to a significantly higher risk of developing breast cancer for women, according to a new study out of Harvard Medical School. The findings suggest it may be possible to test these hormone levels and identify women who may benefit the most from a prescription to buy Tamoxifen.
For the study, the researchers analyzed blood samples taken from a group of nurses nine years before the investigation began. They then looked at the health records of these participants.
The results showed that higher levels of any one of eight different sex hormones increased a woman's risk of breast cancer by 16 percent. The more hormones a participant had in excess, the more likely she was to develop tumors.
The researchers said that elevated estrogen and testosterone levels have long been recognized as risk factors for breast cancer, but the new study further deepens medical knowledge of how hormones affect a person's odds of developing cancer.
This could lead to new tests that spot dangerous elevations in hormone levels that could alert doctors to a person's risk at an early stage.
See also ...
|IMPORTANT DISCLOSURE: All medical content and news articles on this website is supplied by an independent third party company. While the information can be useful, this website relies on others for its creation and cannot guarantee the accuracy, medical efficacy, or reliability of the information provided. In all circumstances, you should always seek the advice of your physician and/or other qualified health professional(s) for drug, medical condition, or treatment advice. This website does not provide any medical advice. The content provided on this website is not a substitute for professional medical advice, diagnosis or treatment.|